INICIO / RESULTADOS DE LA BÚSQUEDA
Resultados de la búsqueda
Temas
tipo de enfermedad
Recursos
If you can’t find what you’re looking for, check out our resource hub—featuring FAQs, guides, videos, and more to empower you on your journey to better kidney health.
The FDA Grants Accelerated Approval of ULTOMIRIS (ravulizumab-cwvz) for Adults with IgA Nephropathy
October 2026 — NephCure celebrates another landmark milestone for the rare kidney disease (RKD) community following the U.S. Food and Drug Administration’s (FDA) accelerated approval of ULTOMIRIS® (ravulizumab-cwvz) as the first and only C5 ... Leer más
NephCure Applauds U.S. Department of Health and Human Services on the Release of the Rare Kidney Disease Inclusive Kidney Care National Plan
PHILADELPHIA, PA — October 22, 2026 — NephCure, a leading nonprofit organization advocating to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments ... Leer más
NephCure Celebrates C3G Awareness Day on September 25, 2026
NephCure, a leading nonprofit organization advocating to ensure that all individuals with rare, protein-spilling kidney disease have equitable access to the care and treatments that offer them the best kidney health outcome ... Leer más